Clinical Trial Update: Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on cilostazol and probucol, alone and in combination, evaluating atherosclerosis-related biomarkers in patients with cerebral infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cerebral Infarction

Drugs mentioned

• Probucol (Probucol)
• cilostazol (Pletal) (cilostazol)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Atherosclerosis Cerebral Infarction | Phase 4 | Status: COMPLETED